Aion Therapeutic ANTCF Stock
Aion Therapeutic Price Chart
Aion Therapeutic ANTCF Financial and Trading Overview
Aion Therapeutic stock price | 0.0055 USD |
Previous Close | 0.0036 USD |
Open | 0.0036 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0036 - 0.0036 USD |
52 Week Range | 0.0032 - 0.03 USD |
Volume | 5.56K USD |
Avg. Volume | 1.25K USD |
Market Cap | 553.09K USD |
Beta (5Y Monthly) | 0.768723 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ANTCF Valuation Measures
Enterprise Value | 1.47M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -1.243 |
Trading Information
Aion Therapeutic Stock Price History
Beta (5Y Monthly) | 0.768723 |
52-Week Change | -62.77% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.03 USD |
52 Week Low | 0.0032 USD |
50-Day Moving Average | 0.0057324 USD |
200-Day Moving Average | 0.0095305 USD |
ANTCF Share Statistics
Avg. Volume (3 month) | 1.25K USD |
Avg. Daily Volume (10-Days) | 555 USD |
Shares Outstanding | 147.3M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 17.68% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | April 30, 2022 |
Most Recent Quarter (mrq) | January 31, 2023 |
Next Fiscal Year End | April 30, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -77.31% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -1181812 USD |
Net Income Avi to Common (ttm) | -1152041 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | 938.21K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.072 |
Book Value Per Share (mrq) | -0.013 |
Cash Flow Statement
Operating Cash Flow (ttm) | -181351 USD |
Levered Free Cash Flow (ttm) | -525411 USD |
Profile of Aion Therapeutic
Country | United States |
State | ON |
City | Toronto |
Address | 45 Sheppard Avenue East |
ZIP | M2N 5W9 |
Phone | N/A |
Website | N/A |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Aion Therapeutic Inc. offer medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.
Q&A For Aion Therapeutic Stock
What is a current ANTCF stock price?
Aion Therapeutic ANTCF stock price today per share is 0.0055 USD.
How to purchase Aion Therapeutic stock?
You can buy ANTCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aion Therapeutic?
The stock symbol or ticker of Aion Therapeutic is ANTCF.
Which industry does the Aion Therapeutic company belong to?
The Aion Therapeutic industry is Drug Manufacturers-Specialty & Generic.
How many shares does Aion Therapeutic have in circulation?
The max supply of Aion Therapeutic shares is 641.77M.
What is Aion Therapeutic Price to Earnings Ratio (PE Ratio)?
Aion Therapeutic PE Ratio is now.
What was Aion Therapeutic earnings per share over the trailing 12 months (TTM)?
Aion Therapeutic EPS is -0.01 USD over the trailing 12 months.
Which sector does the Aion Therapeutic company belong to?
The Aion Therapeutic sector is Healthcare.